Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 64

Sort by

Sort Order Select

Journal Articles

Ferritin change and predictors of anemia response in ruxolitinib-intolerant myelofibrosis patients treated with gecacitinib

Yi Zhang, Hu Zhou, Zhijian Xiao, Minghui Duan, Sujun Gao, Guangsheng He, Hongmei Jing, Junmin Li, Liangming Ma, Huanling Zhu, Chunkang Chang, Xin Du, Mei Hong, Xin Li, Qingchi Liu, Wei WANG, Na Xu, Haiping Yang, Jie Jin

Blood (2025) 146 (Supplement 1): 2029.

https://doi.org/10.1182/blood-2025-2029

Published: 2025

Journal Articles

Efficacy and safety of gecacitinib in thrombocytopenic myelofibrosis patients

Blood (2025) 146 (Supplement 1): 2028.

https://doi.org/10.1182/blood-2025-2028

Published: 2025

Journal Articles

LP-005, a bifunctional C5 antibody fusion protein, efficacy and safety in PNH patients with active hemolysis: Updated results from a Phase 2 study at 12/24 weeks

Guangsheng He, Yuemin Gong, Jianyong Li, Wenwei Zhu, Jingnan Sun, Chuan He, Wei Zhang, Cuicui Han, Jie Yang, Heng Liu

Blood (2025) 146 (Supplement 1): 983.

https://doi.org/10.1182/blood-2025-983

Published: 2025

Journal Articles

Severe hemolysis flare of refractory warm hemolytic anemia with positive complement component C3d responsive to iptacopan with cyclophosphamide and prednisone

Yawen Zhang, Chengtao Qin, Yuemin Gong, Jianyong Li, Lei Fan, Guangsheng He

Blood (2025) 146 (Supplement 1): 2880.

https://doi.org/10.1182/blood-2025-2880

Published: 2025

Journal Articles

Long-term outcomes of intensive immunosuppressive therapy combined with eltrombopag in patients with severe aplastic anemia

Chengtao Qin, Yawen Zhang, Yuemin Gong, Jianyong Li, Lei Fan, Guangsheng He

Blood (2025) 146 (Supplement 1): 6431.

https://doi.org/10.1182/blood-2025-6431

Published: 2025

Journal Articles

Efficacy and safety of HSK39297 monotherapy in patients with paroxysmal nocturnal hemoglobinuria (PNH)

Yuemin Gong, Lina Zhang, Zunmin Zhu, Jianda Hu, Zenghua Lin, Wenwei Zhu, Fangqiong Li, Guangsheng He

Blood (2025) 146 (Supplement 1): 4969.

https://doi.org/10.1182/blood-2025-4969

Published: 2025

Journal Articles

The improvement of renal function by complement inhibitors in patients with paroxysmal nocturnal hemoglobinuria

Chengtao Qin, Yuemin Gong, Yawen Zhang, Ting Zhang, Jianyong Li, Lei Fan, Guangsheng He

Blood (2025) 146 (Supplement 1): 2892.

https://doi.org/10.1182/blood-2025-2892

Published: 2025

Journal Articles

Long-term treatment continuation of gecacitinib in myelofibrosis patients after ruxolitinib failure

Blood (2025) 146 (Supplement 1): 5584.

https://doi.org/10.1182/blood-2025-5584

Published: 2025

Journal Articles

Comparisons between Haploidentical Hematopoietic Stem Cell Transplantation and Eltrombopag Adding to Standard Immunosuppression in Patients with Severe Aplastic Anemia

Andie Fu, Mengyuan Li, Yizhou Peng, Bin Xu, Li Li, Jin-song Jia, Yan Yang, Shengyun Lin, Jia Wei, Fankai Meng, Donghua Zhang, Guangsheng He

Blood (2024) 144 (Supplement 1): 3567.

https://doi.org/10.1182/blood-2024-199689

Published: 2024

Journal Articles

Hetrombopag Added to Immunosuppressive Therapy in First-Line Treatment of Severe Aplastic Anemia: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial

Blood (2024) 144 (Supplement 1): 304.

https://doi.org/10.1182/blood-2024-206377

Published: 2024

Journal Articles

Post Hoc Analysis of Phase III Gecacitinib Clinical Trial Outcomes: Enhanced Understanding and Implications

Blood (2024) 144 (Supplement 1): 3165.

https://doi.org/10.1182/blood-2024-202790

Published: 2024

Journal Articles

Torque Teno Viruses Infection Associated with Suboptimal Hematological Recovery of Severe Aplastic Anemia

Yuemin Gong, Yawen Zhang, Jianyong Li, Guangsheng He, Lei Fan

Blood (2024) 144 (Supplement 1): 2702.

https://doi.org/10.1182/blood-2024-202874

Published: 2024

Journal Articles

Combining Intensive Immunosuppressive Therapy with Eltrombopag in the Severe Aplastic Anemia: Mild Aggravation of Hepatic Injury

Xiaoyu Chen, Chengtao Qin, Ting Zhang, Yuemin Gong, Yawen Zhang, Guangsheng He, Jianyong Li

Blood (2024) 144 (Supplement 1): 5678.

https://doi.org/10.1182/blood-2024-203363

Published: 2024

Journal Articles

Gene Mutation Profiles of Primary Pure Red Cell Aplasia and Large Granular Lymphocytic Leukemia Associated Pure Red Cell Aplasia

Yawen Zhang, Yuemin Gong, Xiaoqing Liu, Guangsheng He, Lei Fan, Jianyong Li

Blood (2024) 144 (Supplement 1): 5676.

https://doi.org/10.1182/blood-2024-202927

Published: 2024

Journal Articles

Phase III Randomized COMMODORE 2 Trial: 2-Year Efficacy and Safety of Crovalimab in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Naive to Complement Inhibition

Alexander Röth, Guangsheng He, Andres Brodsky, Chatree Chai-Adisaksopha, Narcisa Sonia Comia, Anna Gaya, Martin Höglund, Richard J. Kelly, Ahlam Naila Kori, Je-Hwan Lee, Naoshi Obara, Antonio M Risitano, Anita Appius, Leigh Beveridge, Brittany Gentile, Zilu Zhang, Bing Han, Sasha Sreckovic

Blood (2024) 144 (Supplement 1): 2687.

https://doi.org/10.1182/blood-2024-208072

Published: 2024

Journal Articles

No Benefits from Glucocorticoid Maintenance Therapy in Patients with PNH

Hui Yang, Xiaoyu Chen, Yuemin Gong, Yawen Zhang, Jinge Xu, Dan Xu, Jianyong Li, Guangsheng He

Blood (2023) 142 (Supplement 1): 5638.

https://doi.org/10.1182/blood-2023-189210

Published: 2023

Journal Articles

Safety of Crovalimab Versus Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH): Pooled Results from the Phase III COMMODORE 1, COMMODORE 2, and COMMODORE 3 Studies

Alexander Roeth, Rong FU, Guangsheng He, Hazza A Alzahrani, Sheng-Chieh Chou, Yosr Hicheri, Maciej Kazmierczak, Viviane Lacorte Recova, Michihiro Uchiyama, ANA Maria Vladareanu, Leigh Beveridge, Simon Buatois, Muriel Buri, Dayu Shi, Nadiesh Balachandran, Sasha Srekovic, Phillip Scheinberg

Blood (2023) 142 (Supplement 1): 575.

https://doi.org/10.1182/blood-2023-177618

Published: 2023

Journal Articles

In Vivo Effects of Porcine and Rabbit Antithymocyte Globulin in Patients with Severe Aplastic Anemia

Yawen Zhang, Yingying Zhang, Anqi Xiong, Yuemin Gong, Xiaoyu Chen, Yu Sun, Guangsheng He, Jianyong Li

Blood (2023) 142 (Supplement 1): 5630.

https://doi.org/10.1182/blood-2023-182856

Published: 2023

Journal Articles

The Efficacy of Hetrombopag Combined with Cyclosporine a in Patients with Transfusion-Dependent Non-Severe Aplastic Anemia

Yuemin Gong, Xiaoyu Chen, Yawen Zhang, Guangsheng He, Jianyong Li

Blood (2023) 142 (Supplement 1): 1343.

https://doi.org/10.1182/blood-2023-182723

Published: 2023

Journal Articles

Clinical Features and Outcomes in Large Granular Lymphocyte Leukemia-Associated Pure Red Cell Aplasia with STAT3 Mutation

Xiaoqing Liu, Xiaoyu Chen, Yuemin Gong, Qiqiang Long, Guangsheng He, Jianyong Li

Blood (2023) 142 (Supplement 1): 1353.

https://doi.org/10.1182/blood-2023-186337

Published: 2023

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Ferritin change and predictors of anemia response in ruxolitinib-intolerant myelofibrosis patients treated with gecacitinib

Efficacy and safety of gecacitinib in thrombocytopenic myelofibrosis patients

LP-005, a bifunctional C5 antibody fusion protein, efficacy and safety in PNH patients with active hemolysis: Updated results from a Phase 2 study at 12/24 weeks

Severe hemolysis flare of refractory warm hemolytic anemia with positive complement component C3d responsive to iptacopan with cyclophosphamide and prednisone

Long-term outcomes of intensive immunosuppressive therapy combined with eltrombopag in patients with severe aplastic anemia

Efficacy and safety of HSK39297 monotherapy in patients with paroxysmal nocturnal hemoglobinuria (PNH)

The improvement of renal function by complement inhibitors in patients with paroxysmal nocturnal hemoglobinuria

Long-term treatment continuation of gecacitinib in myelofibrosis patients after ruxolitinib failure

Comparisons between Haploidentical Hematopoietic Stem Cell Transplantation and Eltrombopag Adding to Standard Immunosuppression in Patients with Severe Aplastic Anemia

Hetrombopag Added to Immunosuppressive Therapy in First-Line Treatment of Severe Aplastic Anemia: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial

Post Hoc Analysis of Phase III Gecacitinib Clinical Trial Outcomes: Enhanced Understanding and Implications

Torque Teno Viruses Infection Associated with Suboptimal Hematological Recovery of Severe Aplastic Anemia

Combining Intensive Immunosuppressive Therapy with Eltrombopag in the Severe Aplastic Anemia: Mild Aggravation of Hepatic Injury

Gene Mutation Profiles of Primary Pure Red Cell Aplasia and Large Granular Lymphocytic Leukemia Associated Pure Red Cell Aplasia

Phase III Randomized COMMODORE 2 Trial: 2-Year Efficacy and Safety of Crovalimab in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Naive to Complement Inhibition

No Benefits from Glucocorticoid Maintenance Therapy in Patients with PNH

Safety of Crovalimab Versus Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH): Pooled Results from the Phase III COMMODORE 1, COMMODORE 2, and COMMODORE 3 Studies

In Vivo Effects of Porcine and Rabbit Antithymocyte Globulin in Patients with Severe Aplastic Anemia

The Efficacy of Hetrombopag Combined with Cyclosporine a in Patients with Transfusion-Dependent Non-Severe Aplastic Anemia

Clinical Features and Outcomes in Large Granular Lymphocyte Leukemia-Associated Pure Red Cell Aplasia with STAT3 Mutation

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only